AriBioLab Co.,Ltd. (KOSDAQ:261780)
South Korea · Delayed Price · Currency is KRW 3,850.00
-115.00 (-2.90%)
At close: Nov 5, 2026
AriBioLab Market Cap
AriBioLab has a market cap or net worth of 107.85 billion as of November 5, 2026. It is the 26,502nd most valuable company in the world and the 1,170th biggest in South Korea. Its market cap has increased by 48.41% in one year.
Market Cap
107.85B
Enterprise Value
98.40B
Revenue
173.16M
Global Rank
Country Rank
#1,170 South Korea
PE Ratio
n/a
ChartMarket Cap Chart
Since October 22, 2021, AriBioLab's market cap has decreased from 343.58B to 107.85B, a decrease of -68.61%. That is a compound annual growth rate of -20.53%.
| Date | Market Cap | % Change |
|---|---|---|
| Nov 5, 2026 | 107.85B | 42.11% |
| Dec 30, 2025 | 75.89B | -7.54% |
| Dec 30, 2024 | 82.08B | -45.65% |
| Dec 28, 2023 | 151.04B | 14.64% |
| Dec 29, 2022 | 131.75B | -55.09% |
| Dec 30, 2021 | 293.36B | -14.62% |
| Oct 22, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| ISU Abxis | 130.48B |
| Kanaph Therapeutics | 125.42B |
| Bio Solution | 124.76B |
| Ensol Biosciences | 123.64B |
| Y-Biologics | 120.01B |
| TiumBio | 107.84B |
| Cell Biotech | 101.02B |
| ViGenCell | 92.55B |